Zum Hauptinhalt springen
  • Eintragen
    Herzlich willkommen!
    Mein Konto
    Abmeldung

W. P. Carey Inc. (WPC) Aktienprognose 2025 - KI-Preisvorhersage & Analyse

W. P. Carey Inc. (WPC) AI-Aktienkursprognose & Investitionsanalyse

W. P. Carey Inc. Aktienkurs-Chart und technische Analyse

Loading W. P. Carey Inc. interaktives Kursdiagramm und technische Analyse...

W. P. Carey Inc. (WPC) - Umfassende Aktienanalyse & Investment Research

Deep dive into W. P. Carey Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about W. P. Carey Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Für W. P. Carey Inc.: W. P. Carey Inc. operates in the Real Estate & Construction sector, positioning it as a large-cap market leader.

W. P. Carey Inc. (Börsenkürzel: WPC) ist ein führendes Unternehmen in der Real Estate & Construction Branche die speziell in der Branche Real Estate Investment Trusts tätig sind.

Die Organisation beschäftigt weltweit etwa 204 Fachkräfte .

Das Unternehmen hat sich etabliert als ein bedeutender Marktführer mit großem institutionellen Rückhalt.

Understanding Financial Performance

Was diese Metriken bedeuten: Key financial indicators showing W. P. Carey Inc.'s revenue scale, profitability, market value, and shareholder returns.

Wie man sie liest: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Für W. P. Carey Inc.: With $1644M in annual revenue and 35,1% net margin, the company demonstrates exceptional profitability.

Jährliche Einnahmen: $1644 Millionen Erzielung einer 35,1% Nettogewinnspanne .

Marktkapitalisierung: $14903 Millionen - Einstufung als Large-Cap-Aktien mit institutioneller Stabilität.

Eigenkapitalrendite (ROE): 7,1% - Unterdurchschnittlich Effizienz der Aktionärsrendite, was darauf hindeutet Bereiche für operative Verbesserungen.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for W. P. Carey Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Für W. P. Carey Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Premium-KI-Vorhersagen freischalten um auf unsere fortschrittlichen Machine-Learning-Prognosen für die W. P. Carey Inc.-Aktie zuzugreifen, einschließlich 7-Tage-, 30-Tage- und 90-Tage-Kurszielen mit Konfidenzintervallen und Risikoeinschätzungen.

Understanding Market Position

What this analysis covers: W. P. Carey Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Für W. P. Carey Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

W. P. Carey Inc. konkurriert strategisch auf dem hochdynamischen Real Estate Investment Trusts marktplatz, Positionierung als marktbeherrschender Large-Cap-Anbieter mit bedeutenden Wettbewerbsvorteilen und dem Vertrauen institutioneller Anleger .

Das Unternehmen demonstriert robuste operative Effizienz durch einen starken freien Cashflow von $974 Millionen jährlichergänzt durch ein beeindruckendes -1,3% jährliches Cashflow-Wachstum.

Das Unternehmen weist eine gesunde 53,4% Bruttomarge auf, was auf eine starke Preissetzungsmacht und betriebliche Effizienz hindeutet.

W. P. Carey Inc. (WPC) Fundamentalanalyse & Insiderhandelsdaten (Vierteljährliche Finanzberichte)

Umfassende vierteljährliche Finanzdaten, Gewinntrends, Insidertransaktionen und institutionelle Beteiligungen für W. P. Carey Inc. Aktienanalyse.

Loading W. P. Carey Inc. umfassende Fundamentalanalyse und Insiderhandelsdaten...

Tiefe Einblicke in die finanzielle Gesundheit, die Bewertungskennzahlen und die betriebliche Effizienz von W. P. Carey Inc., um fundierte Investitionsentscheidungen zu treffen.

Bewertungsmetriken verstehen

Was diese Metriken bedeuten: Mit Hilfe von Bewertungskennzahlen lässt sich feststellen, ob eine W. P. Carey Inc.-Aktie im Vergleich zu ihren Erträgen, Vermögenswerten und ihrer Marktposition einen fairen Preis hat.

Wie man sie liest: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Für W. P. Carey Inc.: Bei einem Kurs-Gewinn-Verhältnis von 44,38 ist der Markt schätzt die künftigen Wachstumsaussichten hoch ein.

P/E Ratio 44,38x
P/B Ratio 1,81x
Market Cap $14903M
Dividend Yield 5,26%
EPS $1,52
Buchwert/Aktie $37,11
Umsatz/Aktie $7,43
FCF/Aktie $4,54
Rentabilitätsmetriken verstehen

Was diese Metriken bedeuten: Diese Kennzahlen messen, wie effizient W. P. Carey Inc. Einnahmen in Gewinn umwandelt und Renditen für die Aktionäre erwirtschaftet.

Wie man sie liest: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Für W. P. Carey Inc.: Eine Eigenkapitalrendite von 7,1% zeigt Raum für Verbesserungen bei Wertschöpfung für die Aktionäre.

ROE 7,1%
ROA 3,4%
ROIC 5,0%
Gross Margin 53,4%
Operating Margin 47,4%
Net Margin 35,1%
EBT Margin 39,8%
Tax Rate 5,5%
Finanzielle Gesundheitsmetriken verstehen

Was diese Metriken bedeuten: Diese Kennzahlen bewerten die Fähigkeit von W. P. Carey Inc., kurzfristigen Verpflichtungen nachzukommen und den Schuldenstand effektiv zu verwalten.

Wie man sie liest: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Für W. P. Carey Inc.: Ein aktuelles Verhältnis von 0,28 deutet auf potenzielle Liquiditätsprobleme hin.

Current Ratio 0,28x
Quick Ratio 0,28x
D/E Ratio 0,88x
Financial Leverage 2,02x
Interest Coverage 3,9x
Working Capital $-497M
Cashflow-Metriken verstehen

Was diese Metriken bedeuten: Die Cashflow-Kennzahlen geben Aufschluss über die Fähigkeit von W. P. Carey Inc., Mittel aus dem operativen Geschäft zu generieren und Wachstumsinitiativen zu finanzieren.

Wie man sie liest: Ein positiver operativer Cashflow ist entscheidend. Der freie Cashflow zeigt, wie viel Geld für Dividenden, Rückkäufe oder Investitionen zur Verfügung steht.

Für W. P. Carey Inc.: Freier Cashflow von $974M bietet Flexibilität für Aktionärsrenditen und Wachstumsinvestitionen.

Operating Cash Flow $974M
Free Cash Flow $974M
Capital Spending $-15M
OCF Growth YoY -1,3%
FCF Growth YoY -1,3%
FCF/Sales 71,2%
CapEx/Sales 1,8%
Metriken für die betriebliche Effizienz verstehen

Was diese Metriken bedeuten: Diese Kennzahlen messen, wie effektiv W. P. Carey Inc. sein Vermögen einsetzt und das Betriebskapital verwaltet.

Wie man sie liest: Höhere Umschlagshäufigkeiten deuten auf eine effiziente Nutzung der Vermögenswerte hin. Kürzere Inkassofristen zeigen ein effizientes Kreditmanagement.

Für W. P. Carey Inc.: Ein Vermögensumschlag von 0,09x deutet darauf hin, dass es Raum für Verbesserungen bei Anlagennutzung.

Asset Turnover 0,09x
Receivables Turnover 2012,9x
Fixed Assets Turnover 0,6x
Offene Verkaufstage 0 Tage
Verbindlichkeiten Zeitraum 1675 Tage
Verstehen von Jahresabschlussdaten

Was diese Metriken bedeuten: Schlüsselzahlen aus der Gewinn- und Verlustrechnung und der Bilanz von W. P. Carey Inc., die die absolute finanzielle Leistung zeigen.

Wie man sie liest: Die Einnahmen zeigen die Größe des Unternehmens, während die Gewinnspannen die Rentabilität anzeigen. Die Bilanzposten geben Aufschluss über die Finanzstruktur.

Für W. P. Carey Inc.: Mit einem Jahresumsatz von $1644M, W. P. Carey Inc. in erheblichem Umfang tätig ist.

Gewinn- und Verlustrechnung ($ Millionen)
Gesamteinnahmen $1644M
Betriebseinkommen $648M
SG&A-Aufwand $8M
Kosten der verkauften Waren $9M
Highlights der Bilanz (% Of Assets)
Total Current Assets 1%
Cash & Short-term Investments 1%
Total Liabilities 51%
Short-term Debt 16%
Accounts Receivable 0%
Informationen zu Dividende und Aktionären
Dividends Per Share $3,54
Payout Ratio 2,3%
Shares Outstanding 221M
Wachstumsmetriken (YoY)
EPS Growth 0,9%

Neueste W. P. Carey Inc. Aktiennachrichten und Marktanalysen

Aktuelle Nachrichten, Analystenberichte und Marktaktualisierungen, die den Aktienkurs und die Investitionsaussichten von W. P. Carey Inc. (WPC) betreffen.

📰 Wir aktualisieren derzeit unseren Newsfeed für W. P. Carey Inc.. Schauen Sie bald wieder vorbei, um die neuesten Marktanalysen und Unternehmens-Updates zu erhalten.

W. P. Carey Inc. Wettbewerber und Peer-Analyse - Real Estate & Construction Sektor

Vergleichende Analyse von W. P. Carey Inc. mit Branchenkollegen und Wettbewerbern im Real Estate & Construction-Sektor, mit KI-gestützten Prognosen und wichtigen Finanzkennzahlen.

Unternehmen Ticker-Symbol 90-Tage-Prognose für AI Marktkapitalisierung (USD Mio.) Kurs-Gewinn-Verhältnis P/B-Verhältnis
AAT Unlock Forecast - 30 Days FREE Trial $1499M 15,9x 1,3x
ABR Unlock Forecast - 30 Days FREE Trial $2590M 12,1x 0,9x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3979M 18,6x 1,3x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3935M 18,4x 1,3x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4866M 22,8x 1,6x
ACR Unlock Forecast - 30 Days FREE Trial $159M 7,3x 0,4x
ACRE Unlock Forecast - 30 Days FREE Trial $282M 8,5x 0,5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $191M 8,8x 0,5x
ACR-PD Unlock Forecast - 30 Days FREE Trial $167M 7,7x 0,4x
ADC Unlock Forecast - 30 Days FREE Trial $8037M 43,3x 1,4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2010M 10,8x 0,4x
AGNC Unlock Forecast - 30 Days FREE Trial $10771M 28,5x 1,0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26376M 69,8x 2,6x
AGNCM Unlock Forecast - 30 Days FREE Trial $26043M 68,9x 2,5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26824M 71,0x 2,6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26688M 70,6x 2,6x
AGNCP Unlock Forecast - 30 Days FREE Trial $26230M 69,4x 2,5x
AHR Unlock Forecast - 30 Days FREE Trial $6933M x 2,9x
AHT Unlock Forecast - 30 Days FREE Trial $19M -1,5x -0,1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $54M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $51M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $45M x x
AIV Unlock Forecast - 30 Days FREE Trial $3315M -6,0x 36,2x
AJX Unlock Forecast - 30 Days FREE Trial $133M -0,8x 0,5x
AKR Unlock Forecast - 30 Days FREE Trial $2429M 470,2x 1,1x
ALEX Unlock Forecast - 30 Days FREE Trial $1385M 17,8x 1,4x
ALX Unlock Forecast - 30 Days FREE Trial $1204M 32,2x 8,3x
AMH Unlock Forecast - 30 Days FREE Trial $332M 39,2x 0,1x
AMT Unlock Forecast - 30 Days FREE Trial $256165M 198,2x 69,0x
APLE Unlock Forecast - 30 Days FREE Trial $3048M 16,8x 1,0x
ARE Unlock Forecast - 30 Days FREE Trial $18446M 55,8x 1,1x
ARI Unlock Forecast - 30 Days FREE Trial $1529M -9,0x 0,8x
ARR Unlock Forecast - 30 Days FREE Trial $1379M -6,0x 0,8x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1909M x 1,2x
AVB Unlock Forecast - 30 Days FREE Trial $28305M 24,4x 2,4x
BDN Unlock Forecast - 30 Days FREE Trial $764M -5,2x 0,9x
BFS Unlock Forecast - 30 Days FREE Trial $1208M 28,0x 3,8x
BFS-PD Unlock Forecast - 30 Days FREE Trial $826M 19,2x 2,6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $870M 20,2x 2,7x
BHM Unlock Forecast - 30 Days FREE Trial $227M 83,0x 1,7x
BHR Unlock Forecast - 30 Days FREE Trial $597M -3,1x 2,7x
BHR-PB Unlock Forecast - 30 Days FREE Trial $3269M x 14,5x
BHR-PD Unlock Forecast - 30 Days FREE Trial $4058M x 18,0x
BMNM Unlock Forecast - 30 Days FREE Trial $14M x 0,6x
BNL Unlock Forecast - 30 Days FREE Trial $3814M 38,6x 1,3x
BRSP Unlock Forecast - 30 Days FREE Trial $751M -6,6x 0,8x
BRT Unlock Forecast - 30 Days FREE Trial $282M -37,6x 1,5x
BRX Unlock Forecast - 30 Days FREE Trial $8544M 25,5x 2,9x
BXMT Unlock Forecast - 30 Days FREE Trial $3301M -17,4x 0,9x
BXP Unlock Forecast - 30 Days FREE Trial $17966M 3640,5x 3,4x
CBL Unlock Forecast - 30 Days FREE Trial $949M 14,4x 3,3x
CCI Unlock Forecast - 30 Days FREE Trial $46333M 36,6x 6,1x
CDP Unlock Forecast - 30 Days FREE Trial $3615M 24,1x 2,4x
CDR-PB Unlock Forecast - 30 Days FREE Trial $244M 44,3x 10,9x
CDR-PC Unlock Forecast - 30 Days FREE Trial $220M 39,8x 9,8x
CHCT Unlock Forecast - 30 Days FREE Trial $443M -220,9x 1,0x
CHMI Unlock Forecast - 30 Days FREE Trial $106M -9,3x 0,5x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $842M x 3,7x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $882M x 3,8x
CHTH Unlock Forecast - 30 Days FREE Trial $603M x 0,9x
CIM Unlock Forecast - 30 Days FREE Trial $1217M 6,3x 0,5x
CIMN Unlock Forecast - 30 Days FREE Trial $2081M 10,8x 0,8x
CIMO Unlock Forecast - 30 Days FREE Trial $2091M 10,9x 0,8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1862M 9,7x 0,7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $2005M 10,4x 0,8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1915M 9,9x 0,7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1995M 10,4x 0,8x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15,4x 0,5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1010M x 1,6x
CLDT Unlock Forecast - 30 Days FREE Trial $388M 41,0x 0,5x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1101M 116,5x 1,5x
CLPR Unlock Forecast - 30 Days FREE Trial $73M -10,4x -20,5x
CMCT Unlock Forecast - 30 Days FREE Trial $6M -0,1x 0,0x
CMRF Unlock Forecast - 30 Days FREE Trial $1241M x 0,7x
COLD Unlock Forecast - 30 Days FREE Trial $3902M -26,5x 1,3x
CPT Unlock Forecast - 30 Days FREE Trial $12240M 78,5x 2,7x
CSR Unlock Forecast - 30 Days FREE Trial $1206M -74,6x 1,7x
CTO Unlock Forecast - 30 Days FREE Trial $574M 41,8x 1,0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $730M x 1,3x
CTRE Unlock Forecast - 30 Days FREE Trial $6938M 31,6x 2,1x
CUBE Unlock Forecast - 30 Days FREE Trial $9688M 25,9x 3,4x
CUZ Unlock Forecast - 30 Days FREE Trial $4927M 81,8x 1,0x
CXW Unlock Forecast - 30 Days FREE Trial $2189M 21,0x 1,5x
DEA Unlock Forecast - 30 Days FREE Trial $1029M 65,3x 0,8x
DEI Unlock Forecast - 30 Days FREE Trial $4888M 129,7x 2,4x
DHC Unlock Forecast - 30 Days FREE Trial $995M -1,7x 0,5x
DHCNI Unlock Forecast - 30 Days FREE Trial $4225M -10,4x 2,3x
DHCNL Unlock Forecast - 30 Days FREE Trial $3981M x 2,0x
DLR Unlock Forecast - 30 Days FREE Trial $60397M 43,7x 2,6x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $8355M 6,0x 0,4x
DLR-PK Unlock Forecast - 30 Days FREE Trial $9314M 6,7x 0,4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $8104M 5,9x 0,4x
DOC Unlock Forecast - 30 Days FREE Trial $13818M 83,8x 1,7x
DRH Unlock Forecast - 30 Days FREE Trial $1764M 26,0x 1,1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5413M 79,8x 3,4x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1376M 41,8x 1,8x
DX-PC Unlock Forecast - 30 Days FREE Trial $M x x
EARN Unlock Forecast - 30 Days FREE Trial $212M -11,6x 0,9x
EGP Unlock Forecast - 30 Days FREE Trial $8798M 37,2x 2,6x
ELME Unlock Forecast - 30 Days FREE Trial $1514M -114,5x 1,5x
ELS Unlock Forecast - 30 Days FREE Trial $12904M 25,8x 7,5x
EPR Unlock Forecast - 30 Days FREE Trial $0M 18,4x 0,0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PE Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PG Unlock Forecast - 30 Days FREE Trial $M x x
EPRT Unlock Forecast - 30 Days FREE Trial $6048M 27,0x 1,6x
EQC Unlock Forecast - 30 Days FREE Trial $177M 2,3x 0,1x
EQIX Unlock Forecast - 30 Days FREE Trial $75118M 75,6x 5,3x
EQR Unlock Forecast - 30 Days FREE Trial $25472M 28,0x 2,3x
ESRT Unlock Forecast - 30 Days FREE Trial $0M 52,3x 0,0x
ESS Unlock Forecast - 30 Days FREE Trial $17731M 22,2x 3,2x
EXR Unlock Forecast - 30 Days FREE Trial $33211M 34,0x 2,4x
FBRT Unlock Forecast - 30 Days FREE Trial $1031M 9,4x 0,7x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1885M 17,2x 1,3x
FCPT Unlock Forecast - 30 Days FREE Trial $2656M 25,1x 1,8x
FPI Unlock Forecast - 30 Days FREE Trial $521M 53,4x 0,8x
FR Unlock Forecast - 30 Days FREE Trial $7141M 26,3x 2,7x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0,0x 0,0x
FRT Unlock Forecast - 30 Days FREE Trial $9463M 27,3x 2,9x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1959M 5,7x 0,6x
FSP Unlock Forecast - 30 Days FREE Trial $174M -1,9x 0,3x
FVR Unlock Forecast - 30 Days FREE Trial $508M x 1,4x
GIPR Unlock Forecast - 30 Days FREE Trial $-118M -0,8x 17,0x
GIPRW Unlock Forecast - 30 Days FREE Trial $1M x 0,2x
GLPI Unlock Forecast - 30 Days FREE Trial $14692M 20,5x 3,2x
GMRE Unlock Forecast - 30 Days FREE Trial $530M 51,5x 1,1x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1761M 171,1x 3,5x
GNL Unlock Forecast - 30 Days FREE Trial $1622M -4,5x 0,9x
GPMT Unlock Forecast - 30 Days FREE Trial $146M -0,9x 0,3x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $985M x 1,7x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2657M x 3,0x
HHH Unlock Forecast - 30 Days FREE Trial $3476M -4,8x 1,3x
HIW Unlock Forecast - 30 Days FREE Trial $3611M 27,5x 1,5x
HR Unlock Forecast - 30 Days FREE Trial $5686M -11,5x 1,1x
HST Unlock Forecast - 30 Days FREE Trial $12369M 18,8x 1,9x
HTIA Unlock Forecast - 30 Days FREE Trial $414M -7,6x 0,6x
HTIBP Unlock Forecast - 30 Days FREE Trial $405M -7,3x 0,6x
ICRP Unlock Forecast - 30 Days FREE Trial $81M 7,2x 0,3x
ICR-PA Unlock Forecast - 30 Days FREE Trial $196M 17,3x 0,8x
IHT Unlock Forecast - 30 Days FREE Trial $2M -57,7x 0,6x
ILPT Unlock Forecast - 30 Days FREE Trial $744M -2,3x 1,4x
IMPM Unlock Forecast - 30 Days FREE Trial $2M x x
INN Unlock Forecast - 30 Days FREE Trial $903M 104,9x 1,0x
INN-PE Unlock Forecast - 30 Days FREE Trial $3414M 396,4x 3,8x
INN-PF Unlock Forecast - 30 Days FREE Trial $3372M 391,5x 3,8x
IOR Unlock Forecast - 30 Days FREE Trial $75M 12,5x 0,6x
IRET Unlock Forecast - 30 Days FREE Trial $317M 16,7x 0,5x
IRM Unlock Forecast - 30 Days FREE Trial $29130M 202,7x -41,7x
IRT Unlock Forecast - 30 Days FREE Trial $4340M 156,4x 1,3x
IVR Unlock Forecast - 30 Days FREE Trial $529M 13,1x 0,8x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1632M 40,3x 2,3x
IVT Unlock Forecast - 30 Days FREE Trial $2300M 20,5x 1,3x
JBGS Unlock Forecast - 30 Days FREE Trial $1327M -11,3x 0,7x
KBSR Unlock Forecast - 30 Days FREE Trial $21M x 0,1x
KIM Unlock Forecast - 30 Days FREE Trial $15537M 26,0x 1,5x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14826M 24,8x 1,4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $15178M 25,4x 1,4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $41959M 70,2x 4,0x
KRC Unlock Forecast - 30 Days FREE Trial $5280M 24,1x 1,0x
KREF Unlock Forecast - 30 Days FREE Trial $700M 952,5x 0,6x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1409M x 1,1x
KRG Unlock Forecast - 30 Days FREE Trial $5176M 27,7x 1,6x
LADR Unlock Forecast - 30 Days FREE Trial $0M 15,1x 0,0x
LAMR Unlock Forecast - 30 Days FREE Trial $13138M 29,9x 14,5x
LAND Unlock Forecast - 30 Days FREE Trial $373M -54,4x 0,5x
LANDM Unlock Forecast - 30 Days FREE Trial $900M -119,7x 1,3x
LANDO Unlock Forecast - 30 Days FREE Trial $723M -104,0x 1,1x
LANDP Unlock Forecast - 30 Days FREE Trial $722M -103,5x 1,1x
LFT Unlock Forecast - 30 Days FREE Trial $122M 8,6x 0,5x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1131M 79,4x 4,9x
LINE Unlock Forecast - 30 Days FREE Trial $10231M x 1,2x
LOAN Unlock Forecast - 30 Days FREE Trial $62M 11,2x 1,4x
LTC Unlock Forecast - 30 Days FREE Trial $1838M 22,1x 1,9x
LXP Unlock Forecast - 30 Days FREE Trial $2709M 31,0x 1,3x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14076M 160,9x 6,8x
MAA Unlock Forecast - 30 Days FREE Trial $17518M 30,6x 3,0x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6948M 12,2x 1,2x
MAC Unlock Forecast - 30 Days FREE Trial $4827M -64,7x 1,9x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8,9x 1,1x
MDRRP Unlock Forecast - 30 Days FREE Trial $28M -16,5x 2,3x
MDV Unlock Forecast - 30 Days FREE Trial $219M -24,6x 1,3x
MDV-PA Unlock Forecast - 30 Days FREE Trial $364M x 2,2x
MFA Unlock Forecast - 30 Days FREE Trial $1095M 8,5x 0,6x
MFAN Unlock Forecast - 30 Days FREE Trial $2651M 20,6x 1,5x
MFAO Unlock Forecast - 30 Days FREE Trial $2662M 20,7x 1,5x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2288M 17,8x 1,3x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2552M 19,9x 1,4x
MITN Unlock Forecast - 30 Days FREE Trial $757M 16,3x 1,4x
MITP Unlock Forecast - 30 Days FREE Trial $753M 16,2x 1,4x
MITT Unlock Forecast - 30 Days FREE Trial $232M 5,0x 0,4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $685M 14,8x 1,3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $672M 14,5x 1,3x
MITT-PC Unlock Forecast - 30 Days FREE Trial $750M 16,2x 1,4x
MKZR Unlock Forecast - 30 Days FREE Trial $133M x 2,0x
MPW Unlock Forecast - 30 Days FREE Trial $2719M -1,3x 0,6x
NHHS Unlock Forecast - 30 Days FREE Trial $340M 3,0x 1,4x
NHI Unlock Forecast - 30 Days FREE Trial $3682M 25,8x 2,5x
NHPAP Unlock Forecast - 30 Days FREE Trial $452M x 0,7x
NHPBP Unlock Forecast - 30 Days FREE Trial $454M x 0,7x
NLCP Unlock Forecast - 30 Days FREE Trial $292M 11,2x 0,7x
NLOP Unlock Forecast - 30 Days FREE Trial $439M x 0,9x
NLY Unlock Forecast - 30 Days FREE Trial $13285M -22,9x 1,0x
NNN Unlock Forecast - 30 Days FREE Trial $8095M 20,6x 1,9x
NREF Unlock Forecast - 30 Days FREE Trial $269M -28,2x 2,5x
NREF-PA Unlock Forecast - 30 Days FREE Trial $M x x
NSA Unlock Forecast - 30 Days FREE Trial $2861M 26,1x 2,8x
NTST Unlock Forecast - 30 Days FREE Trial $1549M 1247,7x 1,2x
NXDT Unlock Forecast - 30 Days FREE Trial $181M -1,9x 0,2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $681M x 0,9x
NXRT Unlock Forecast - 30 Days FREE Trial $880M 16,6x 2,5x
NYC Unlock Forecast - 30 Days FREE Trial $35M -0,1x 0,5x
NYMT Unlock Forecast - 30 Days FREE Trial $684M 11,0x 0,5x
NYMTG Unlock Forecast - 30 Days FREE Trial $2313M 37,2x 1,7x
NYMTI Unlock Forecast - 30 Days FREE Trial $2322M 37,4x 1,7x
NYMTL Unlock Forecast - 30 Days FREE Trial $2059M 33,1x 1,5x
NYMTM Unlock Forecast - 30 Days FREE Trial $2315M 37,3x 1,7x
NYMTN Unlock Forecast - 30 Days FREE Trial $2003M 32,2x 1,5x
NYMTZ Unlock Forecast - 30 Days FREE Trial $1660M 26,7x 1,2x
O Unlock Forecast - 30 Days FREE Trial $54324M 59,3x 1,4x
OHI Unlock Forecast - 30 Days FREE Trial $10939M 27,3x 2,3x
OLP Unlock Forecast - 30 Days FREE Trial $501M 25,4x 1,7x
ONL Unlock Forecast - 30 Days FREE Trial $170M -2,5x 0,2x
ORC Unlock Forecast - 30 Days FREE Trial $910M 142,0x 1,0x
OUT Unlock Forecast - 30 Days FREE Trial $4003M 37,2x 7,4x
PCH Unlock Forecast - 30 Days FREE Trial $3331M 80,0x 1,7x
PCOK Unlock Forecast - 30 Days FREE Trial $180M x 5,5x
PEB Unlock Forecast - 30 Days FREE Trial $1448M -21,5x 0,6x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2468M x 0,9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2532M x 1,0x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2464M x 0,9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2230M x 0,8x
PECO Unlock Forecast - 30 Days FREE Trial $5626M 81,7x 2,5x
PGRE Unlock Forecast - 30 Days FREE Trial $1392M -5,8x 0,5x
PINE Unlock Forecast - 30 Days FREE Trial $265M 169,3x 1,2x
PKST Unlock Forecast - 30 Days FREE Trial $518M -3,7x 0,7x
PLD Unlock Forecast - 30 Days FREE Trial $117940M 34,2x 2,2x
PLDGP Unlock Forecast - 30 Days FREE Trial $58098M 16,9x 1,1x
PLYM Unlock Forecast - 30 Days FREE Trial $705M 59,5x 1,2x
PMT Unlock Forecast - 30 Days FREE Trial $1096M 10,4x 0,6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2111M 20,1x 1,1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2094M 19,9x 1,1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1630M 15,5x 0,9x
PMTU Unlock Forecast - 30 Days FREE Trial $2221M 21,1x 1,2x
PMTV Unlock Forecast - 30 Days FREE Trial $2213M 21,0x 1,2x
PMTW Unlock Forecast - 30 Days FREE Trial $2206M 21,0x 1,2x
PSA Unlock Forecast - 30 Days FREE Trial $52425M 29,0x 5,6x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3883M 2,1x 0,4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3791M 2,1x 0,4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4228M 2,3x 0,5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3583M 2,0x 0,4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3469M 1,9x 0,4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3552M 2,0x 0,4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3421M 1,9x 0,4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3052M 1,7x 0,3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2864M 1,6x 0,3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2883M 1,6x 0,3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2953M 1,6x 0,3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2903M 1,6x 0,3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2955M 1,6x 0,3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3031M 1,7x 0,3x
PSTL Unlock Forecast - 30 Days FREE Trial $0M 147,2x 0,0x
PW Unlock Forecast - 30 Days FREE Trial $3M -0,2x 0,6x
PW-PA Unlock Forecast - 30 Days FREE Trial $13M x 2,1x
RC Unlock Forecast - 30 Days FREE Trial $769M -13,0x 0,4x
RCB Unlock Forecast - 30 Days FREE Trial $4373M -44,3x 2,4x
RCC Unlock Forecast - 30 Days FREE Trial $4448M -45,2x 2,4x
RCD Unlock Forecast - 30 Days FREE Trial $4253M x 2,3x
RC-PC Unlock Forecast - 30 Days FREE Trial $2970M x 1,6x
RC-PE Unlock Forecast - 30 Days FREE Trial $2848M x 1,6x
REFI Unlock Forecast - 30 Days FREE Trial $279M 8,1x 0,9x
REG Unlock Forecast - 30 Days FREE Trial $13312M 22,1x 2,0x
REGCO Unlock Forecast - 30 Days FREE Trial $4284M x 0,6x
REGCP Unlock Forecast - 30 Days FREE Trial $4392M x 0,7x
REXR Unlock Forecast - 30 Days FREE Trial $10585M 33,3x 1,2x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5664M 17,8x 0,6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5650M 17,8x 0,6x
RHP Unlock Forecast - 30 Days FREE Trial $10080M 37,7x 12,6x
RITM Unlock Forecast - 30 Days FREE Trial $6987M 8,7x 0,9x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PB Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13952M 17,4x 1,8x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13746M 17,1x 1,7x
RLJ Unlock Forecast - 30 Days FREE Trial $1199M 20,8x 0,5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3755M 65,0x 1,7x
ROIC Unlock Forecast - 30 Days FREE Trial $2248M 45,7x 1,7x
RPT Unlock Forecast - 30 Days FREE Trial $129M -0,8x 0,4x
RWT Unlock Forecast - 30 Days FREE Trial $17M 31,3x 0,0x
RWTN Unlock Forecast - 30 Days FREE Trial $70M x 0,1x
RWTO Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RWTP Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RYN Unlock Forecast - 30 Days FREE Trial $3676M 36,4x 1,9x
SACC Unlock Forecast - 30 Days FREE Trial $1174M 370,5x 5,3x
SACH Unlock Forecast - 30 Days FREE Trial $54M 21,3x 0,3x
SAFE Unlock Forecast - 30 Days FREE Trial $1185M 11,5x 0,5x
SBAC Unlock Forecast - 30 Days FREE Trial $20387M 23,2x -5,1x
SBRA Unlock Forecast - 30 Days FREE Trial $4619M 25,3x 1,7x
SCCC Unlock Forecast - 30 Days FREE Trial $1183M 361,5x 6,6x
SCCD Unlock Forecast - 30 Days FREE Trial $1029M 304,5x 5,7x
SCCE Unlock Forecast - 30 Days FREE Trial $923M 304,8x 5,1x
SCCF Unlock Forecast - 30 Days FREE Trial $907M 279,9x 5,1x
SCCG Unlock Forecast - 30 Days FREE Trial $911M 325,2x 5,1x
SELF Unlock Forecast - 30 Days FREE Trial $60M 24,0x 1,3x
SEVN Unlock Forecast - 30 Days FREE Trial $163M 10,5x 0,6x
SILA Unlock Forecast - 30 Days FREE Trial $1360M x 1,0x
SITC Unlock Forecast - 30 Days FREE Trial $495M 1,4x 1,0x
SKT Unlock Forecast - 30 Days FREE Trial $4084M 38,7x 6,4x
SLG Unlock Forecast - 30 Days FREE Trial $4965M -33,2x 1,3x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1889M x 0,5x
SOHO Unlock Forecast - 30 Days FREE Trial $18M -1,4x 0,4x
SOHOB Unlock Forecast - 30 Days FREE Trial $322M -21,4x 7,0x
SOHON Unlock Forecast - 30 Days FREE Trial $335M -21,8x 7,3x
SOHOO Unlock Forecast - 30 Days FREE Trial $333M -25,6x 7,2x
SPG Unlock Forecast - 30 Days FREE Trial $142M 23,1x 0,1x
SQFT Unlock Forecast - 30 Days FREE Trial $64M 1,2x 1,8x
SQFTP Unlock Forecast - 30 Days FREE Trial $191M 24,7x 5,4x
SQFTW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
STAG Unlock Forecast - 30 Days FREE Trial $6992M 29,9x 2,0x
STLY Unlock Forecast - 30 Days FREE Trial $20M 32,3x 0,5x
STRW Unlock Forecast - 30 Days FREE Trial $663M 111,4x 42,8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0,4x
STWD Unlock Forecast - 30 Days FREE Trial $7822M 21,2x 1,2x
SUI Unlock Forecast - 30 Days FREE Trial $17201M 13,4x 2,3x
SUNS Unlock Forecast - 30 Days FREE Trial $145M 14,5x 0,8x
SVC Unlock Forecast - 30 Days FREE Trial $481M -2,2x 0,7x
TCI Unlock Forecast - 30 Days FREE Trial $412M 62,5x 0,5x
TFSA Unlock Forecast - 30 Days FREE Trial $202M x 0,0x
TPTA Unlock Forecast - 30 Days FREE Trial $563M x 3,3x
TRTX Unlock Forecast - 30 Days FREE Trial $790M 11,8x 0,7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1477M 22,0x 1,4x
TWO Unlock Forecast - 30 Days FREE Trial $1289M -55,6x 0,6x
TWOD Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PA Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PB Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PC Unlock Forecast - 30 Days FREE Trial $M x x
UDR Unlock Forecast - 30 Days FREE Trial $16559M 125,5x 5,0x
UHT Unlock Forecast - 30 Days FREE Trial $574M 32,0x 3,5x
UMH Unlock Forecast - 30 Days FREE Trial $1294M 42,4x 1,4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1924M 63,1x 2,1x
UNIT Unlock Forecast - 30 Days FREE Trial $1760M 49,9x -0,5x
VICI Unlock Forecast - 30 Days FREE Trial $35750M 13,0x 1,3x
VNO Unlock Forecast - 30 Days FREE Trial $9411M 10,8x 1,5x
VNO-PL Unlock Forecast - 30 Days FREE Trial $4291M 4,9x 0,7x
VNO-PM Unlock Forecast - 30 Days FREE Trial $4233M 4,8x 0,7x
VNO-PN Unlock Forecast - 30 Days FREE Trial $4226M 4,8x 0,7x
VNO-PO Unlock Forecast - 30 Days FREE Trial $3528M 4,0x 0,6x
VNORP Unlock Forecast - 30 Days FREE Trial $12723M 14,5x 2,1x
VRE Unlock Forecast - 30 Days FREE Trial $1849M -32,8x 1,7x
VTR Unlock Forecast - 30 Days FREE Trial $31976M 167,2x 2,8x
WELL Unlock Forecast - 30 Days FREE Trial $114671M 101,5x 3,2x
WHLR Unlock Forecast - 30 Days FREE Trial $-9M -4,1x -0,7x
WHLRD Unlock Forecast - 30 Days FREE Trial $-193M -86,0x -4,8x
WHLRL Unlock Forecast - 30 Days FREE Trial $-774M -344,1x -21,2x
WHLRP Unlock Forecast - 30 Days FREE Trial $-22M -9,8x -0,6x
WPC Unlock Forecast - 30 Days FREE Trial $14903M 44,4x 1,8x
WSR Unlock Forecast - 30 Days FREE Trial $693M 20,6x 1,6x
WY Unlock Forecast - 30 Days FREE Trial $18820M 67,5x 2,0x

Häufig gestellte Fragen - W. P. Carey Inc. Aktienprognose

Wie genau sind die W. P. Carey Inc.-Aktienprognosen?

Our AI model demonstrates 59% historical accuracy for WPC predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

Welche Faktoren beeinflussen W. P. Carey Inc. Aktienkursprognosen?

Unsere Analyse berücksichtigt die Finanzkennzahlen von W. P. Carey Inc., Real Estate & Construction Branchentrends, die Marktstimmung, technische Indikatoren, Ertragsdaten und makroökonomische Faktoren, die die Aktienperformance beeinflussen.

Ist W. P. Carey Inc. eine gute Investition im Jahr 2025?

Nach unserer KI-Analyse zeigt W. P. Carey Inc. Potenzial für verschiedene Marktszenarien. Berücksichtigen Sie Ihre Risikotoleranz, Ihren Anlagezeitraum und die Diversifizierung Ihres Portfolios, bevor Sie Anlageentscheidungen treffen.

Wie oft werden die W. P. Carey Inc.-Prognosen aktualisiert?

W. P. Carey Inc. Aktienprognosen werden täglich auf der Grundlage von Echtzeit-Marktdaten aktualisiert, um sicherzustellen, dass Sie die aktuellsten KI-gestützten Vorhersagen und Investitionseinblicke erhalten.

Möchten Sie eine erweiterte W. P. Carey Inc.-Analyse?

Schalten Sie Premium-Funktionen wie detaillierte Kursziele, Risikobewertungen, Portfolio-Optimierung und Echtzeit-Warnungen für W. P. Carey Inc. Aktien frei.

🎯 Premium-Analyse erhalten 📊 Mehr Aktien erforschen

Mein Portfolio

Investitions-Dashboard

Laden Sie Ihr Portfolio...